Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Hinz, Michael Dr. (1) Keller, Ulrich Dr. med. (2) Lusatis, Simone (1) Mathas, Stephan Dr. (13) Na, Il-Kang Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (2) Schmitt, Clemens Prof. Dr. (1) Wollert-Wulf, Brigitte (4) (-) Janz, Martin Dr. (13) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) (-) 2009 (3) 2010 (1) 2011 (4) 2012 (2) (-) 2013 (2) 2014 (1) 2015 (2) 2016 (1) 2017 (3) 2018 (1) 2019 (1) 2020 (4) 2021 (3) (-) 2022 (4) 2023 (6) 2024 (1) Advanced Light Microscopy (1) (-) Biology of Malignant Lymphomas (13) Cancer Genetics and Cellular Stress Responses (1) Cell Biology of Immunity (1) Computational Regulatory Genomics (1) Developmental Biology / Signal Transduction (2) Genetics and Genomics of Cardiovascular Diseases (1) Genome Diversification & Integrity (1) Immune Dysregulations in Oncology (1) Mathematical Modelling of Cellular Processes (1) Mechanism-based Cancer Therapies (2) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (1) Myology (1) Proteome Dynamics (25) Proteomics (2) Proteomics and Metabolomics (1) RNA Biology and Posttranscriptional Regulation (3) Structural Biology of Membrane-Associated Processes (2) Translational Cardiology and Functional Genomics (1) 13 Results: Active Filter: Janz, Martin Dr.Biology of Malignant Lymphomas2006200920132022 Sort: Result score Newest to oldest Oldest to newest July 23, 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz September 26, 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz April 07, 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken February 17, 2022 / N Engl J Med Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma M.R. Bishop M. Dickinson D. Purtill P. Barba A. Santoro N. Hamad K. Kato A. Sureda R. Greil C. Thieblemont F. Morschhauser M. Janz I. Flinn W. Rabitsch Y.L. Kwong M.J Kersten M.C. Minnema H. Holte E.H.L. Chan J. Martinez-Lopez A.M.S. Müller R.T. Maziarz J.P. McGuirk E. Bachy S. Le Gouill M. Dreyling H. Harigae D. Bond C. Andreadis P. McSweeney M. Kharfan-Dabaja S. Newsome E. Degtyarev R. Awasthi C. Del Corral G. Andreola A. Masood S.J. Schuster U. Jäger P. Borchmann J.R. Westin Pagination Current page 1 Page 2 Next page Next › Last page Last »
July 23, 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz
September 26, 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
October 29, 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
September 01, 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
April 07, 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken
February 17, 2022 / N Engl J Med Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma M.R. Bishop M. Dickinson D. Purtill P. Barba A. Santoro N. Hamad K. Kato A. Sureda R. Greil C. Thieblemont F. Morschhauser M. Janz I. Flinn W. Rabitsch Y.L. Kwong M.J Kersten M.C. Minnema H. Holte E.H.L. Chan J. Martinez-Lopez A.M.S. Müller R.T. Maziarz J.P. McGuirk E. Bachy S. Le Gouill M. Dreyling H. Harigae D. Bond C. Andreadis P. McSweeney M. Kharfan-Dabaja S. Newsome E. Degtyarev R. Awasthi C. Del Corral G. Andreola A. Masood S.J. Schuster U. Jäger P. Borchmann J.R. Westin